Skip to main content
. Author manuscript; available in PMC: 2013 Oct 23.
Published in final edited form as: Pancreatology. 2012 Jun 15;12(4):358–363. doi: 10.1016/j.pan.2012.05.011

Table 4.

Pathologic Tumor Characteristics.a

All patients (n = 324) PFH (n =45) NFH (n = 279) P
IPMN Type 0.64
  Main-duct 25 (7.7) 2 (4.4) 23 (8.2)
  Branch-duct 146 (45.1) 20 (44.4) 126 (45.2)
  Combined 153 (47.2) 23 (51.1) 130 (46.6)
Epithelial Type 0.12
  Gastric 191 (59.0) 24 (53.3) 167 (59.9)
  Intestinal 97 (29.9) 12 (26.7) 85 (30.5)
  Oncocyticc 13 (4.0) 1 (2.2) 12 (4.3)
  Pancreatobiliaryc 3 (0.9) 1 (2.2) 2 (0.7)
  Mixedc 20 (6.2) 7 (15.6) 13 (4.7)
Highest Grade 0.62
  Low 59 (18.2) 7 (15.6) 52 (18.6)
  Intermediate 123 (38.0) 20 (44.4) 103 (36.9)
  High 142 (43.8) 18 (40.0) 124 (44.4)
Invasive 65 (20.1) 7 (15.6) 58 (20.8) 0.55
Invasive Typeb 0.50
  Tubular 39 (60.0) 4 (57.1) 35 (60.3)
  Colloid 19 (29.2) 2 (28.6) 17 (29.3)
  Oncocytic 7 (10.8) 1 (14.3) 6 (10.3)
Invasive Sizeb 0.23
  Superficial 23 (35.4) 4 (57.1) 19 (32.8)
  Macroscopic 42 (64.6) 3 (42.9) 39 (67.2)
Concurrent PDAC 13 (4.0) 5 (11.1) 8 (2.9) 0.02
PanIN lesion 143 (44.1) 23 (51.1) 120 (43.0) 0.33
PanIN lesion gradeb 0.68
  1 101 (70.6) 17 (73.9) 84 (70.0)
  2 33 (23.1) 4 (17.4) 29 (24.2)
  3 9 (6.3) 2 (8.7) 7 (5.8)
a

Data presented as number of patients (percentage). P-values represent a comparison of the PFH and NFH groups.

b

Percentages based on number of invasive tumors or PanIN lesions.

c

Pancreaticobiliary, oncocytic and mixed groups combined for chi-square analysis due to the low incidence of these epithelial types.